Hunter Associates Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Sell
2,901
-38
-1% -$7.27K 0.07% 183
2026
Q1
$539K Buy
2,939
+53
+2% +$9.77K 0.07% 188
2025
Q4
$509K Hold
2,886
0.07% 183
2025
Q3
$404K Sell
2,886
-50
-2% -$6.76K 0.06% 198
2025
Q2
$370K Buy
2,936
+30
+1% +$3.74K 0.05% 195
2025
Q1
$398K Buy
2,906
+920
+46% +$132K 0.06% 188
2024
Q4
$304K Sell
1,986
-614
-24% -$104K 0.05% 210
2024
Q3
$504K Hold
2,600
0.08% 175
2024
Q2
$603K Buy
+2,600
New +$565K 0.1% 157
2021
Q3
Sell
-670
Closed -$232K 149
2021
Q2
$232K Sell
670
-90
-12% -$27.3K 0.07% 120
2021
Q1
$213K Buy
+760
New +$205K 0.05% 192
2020
Q3
Sell
-760
Closed -$203K 185
2020
Q2
$203K Hold
760
0.06% 165
2020
Q1
$240K Hold
760
0.09% 126
2019
Q4
$226K Sell
760
-100
-12% -$27.7K 0.07% 151
2019
Q3
$200K Sell
860
-24
-3% -$5.59K 0.07% 156
2019
Q2
$207K Buy
+884
New +$204K 0.07% 157

Other funds holding BIIB

Hunter Associates Investment Management's BIIB Position: Q2 2026 in Review

Hunter Associates Investment Management reduced its Biogen (BIIB) stake by 1.3% in Q2 2026, selling an estimated $7.27K and leaving 2,901 shares worth $626K. The position accounts for 0.07% of the portfolio, ranked #183.

Hunter Associates Investment Management first reported a position in BIIB in Q2 2019 and has held it in 16 quarters since. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Hunter Associates Investment Management held 2,901 shares of Biogen worth $626K as of Q2 2026.
  • Hunter Associates Investment Management sold 38 Biogen shares in Q2 2026, an estimated $7.27K.
  • Biogen made up 0.07% of Hunter Associates Investment Management's portfolio in Q2 2026, its #183 holding.
  • Hunter Associates Investment Management first reported a position in Biogen in Q2 2019 and has held it in 16 quarters since.
  • 684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.